Reducing High Risk Behavior in Treatment Court

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01481428
Recruitment Status : Completed
First Posted : November 29, 2011
Last Update Posted : January 10, 2017
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Treatment Research Institute

November 18, 2011
November 29, 2011
January 10, 2017
September 2012
December 2016   (Final data collection date for primary outcome measure)
Engagement in high risk behaviors [ Time Frame: 15 month follow-up ]
Measured by the Risk Assessment Battery (RAB)
Same as current
Complete list of historical versions of study NCT01481428 on Archive Site
  • Rate of HIV testing [ Time Frame: 15 month follow-up ]
  • Condom Procurement [ Time Frame: 15 month follow-up ]
  • Self-reported Condom Use [ Time Frame: 15 month follow-up ]
Same as current
Not Provided
Not Provided
Reducing High Risk Behavior in Treatment Court
Delivering HIV Risk Reduction Services in Treatment Court
This study will be the first to examine the efficacy of using a brief, computerized HIV risk reduction intervention in treatment courts.
Four hundred consenting treatment drug court participants will be randomly assigned to either an HIV intervention group (n = 200) or an attention control group. All clients will attend their regularly scheduled status hearings which are scheduled approximately every six weeks. Clients in the HIV intervention group will receive a brief computerized, self-administered HIV risk reduction intervention following each of their first three status hearings. Clients in the attention control condition will view a series of educational life-skill videos of matched length following each of their first three status hearings. The primary outcome will be engagement in high risk behaviors as measured by the Risk Assessment Battery (RAB). Secondary HIV-related outcomes will include: (1) rate of HIV testing, (2) condom procurement, and (3) self-reported condom use. Tertiary outcomes related to treatment court compliance will include: (1) drug court graduation, (2) urinalysis-confirmed drug abstinence, (3) case management attendance, and (4) satisfaction with case management. In addition, we will conduct preliminary cost and cost-effectiveness analyses on the delivery of the brief computerized HIV intervention. Assessments will be conducted at baseline and 9- and 15-months post admission.
Phase 1
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Prevention
  • Substance Abuse
  • HIV
  • Behavioral: Computer-facilitated HIV intervention
    Individuals assigned to the experimental condition will complete the self-directed CARE HIV intervention during each of their first three sessions. The 20 minute intervention sessions involve several components including a brief risk assessment, review of identified risks, structured skill building videos, and the development of a risk prevention action plan. Because of the adaptive nature of the CARE program, the content of each session will be tailored to address the current risks of the participant. While the main focus of the intervention is on risk, individuals who report being HIV infected will receive a referral to treatment if they are not currently receiving medical care and their session will address, among other things, adherence to HIV care.
  • Behavioral: Attention Control
    Life skills training DVDs that match the duration of the anticipated experimental condition. The DVDs address topics such as positive listening skills, anger management, and stress reduction.
  • Active Comparator: Attention Control
    Intervention: Behavioral: Attention Control
  • Experimental: Computer-facilitated HIV intervention
    Intervention: Behavioral: Computer-facilitated HIV intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
December 2016
December 2016   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. be at least 18 years of age;
  2. be charged with a non-violent felony offense
  3. have no more than two prior non-violent convictions or diversionary opportunities
  4. be willing to participate in the treatment court program for at least 12 months
  5. be in need of treatment for substance abuse or dependence as assessed by case management.

Exclusion Criteria:

  • Elderly subjects and those with medical problems will be included in the research as long as they do not have any physical or psychiatric condition that would impede their ability to give competent consent to research participation or to understand the research instruments.
  • Those individuals who are intoxicated, cognitively impaired, or psychiatrically unstable when approached will not be included; however, such individuals may subsequently be included if the disqualifying condition subsides.
  • Spanish speaking only individuals.
  • Client remanded to jail or residential treatment facilities at the time of Treatment Court enrollment.
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
Contact information is only displayed when the study is recruiting subjects
United States
R01DA030257 ( U.S. NIH Grant/Contract )
Not Provided
Not Provided
Treatment Research Institute
Treatment Research Institute
National Institute on Drug Abuse (NIDA)
Principal Investigator: David S Festinger, Ph.D. Treatment Research Institute
Treatment Research Institute
January 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP